<- Go Home
Paxman AB (publ)
Paxman AB (publ), together with its subsidiaries, provides cryotherapy solutions in the United Kingdom, Europe, North and South America, Oceania, and Asia. The company offers Paxman scalp cooling system, a mechanized form of scalp cooling for the prevention of chemotherapy-induced alopecia. It also engages in the development of a medical cryocompression device for the prevention of chemotherapy-induced peripheral neuropathy. The company was founded in 1996 and is based in Karlshamn, Sweden.
Market Cap
SEK 1.4B
Volume
38.3K
Cash and Equivalents
SEK 105.6M
EBITDA
SEK 37.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 234.5M
Profit Margin
64.09%
52 Week High
SEK 74.20
52 Week Low
SEK 41.00
Dividend
N/A
Price / Book Value
3.35
Price / Earnings
-219.73
Price / Tangible Book Value
6.04
Enterprise Value
SEK 1.3B
Enterprise Value / EBITDA
34.74
Operating Income
SEK 1.5M
Return on Equity
1.30%
Return on Assets
0.19
Cash and Short Term Investments
SEK 105.6M
Debt
SEK 12.4M
Equity
SEK 416.9M
Revenue
SEK 365.9M
Unlevered FCF
-SEK 30.8M
Sector
Health Care Equipment and Supplies
Category
N/A